Skip to content

Opko Health OPK Equity in earnings (losses) of equity method investees

Equity in earnings (losses) of equity method investees at other companies

Energy Transfer logo
Energy TransferET
$110M+19.6%
Ameriprise Financial logo
Ameriprise FinancialAMP
-$6M+53.8%
The Travelers Companies logo
The Travelers CompaniesTRV
$23M-56.6%
Nucor logo
NucorNUE
$7M+75.0%
Chubb logo
ChubbCB
$157M+91.5%
Elevance Health logo
Elevance HealthELV
$305M+142%

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.14B+11.5%
P/S+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's equity in earnings (losses) of equity method investees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's equity in earnings (losses) of equity method investees?
Opko Health (OPK) reported equity in earnings (losses) of equity method investees of -$2K in Q1 2026.
How has Opko Health's equity in earnings (losses) of equity method investees changed year-over-year?
Opko Health's equity in earnings (losses) of equity method investees increased by 77.8% year-over-year, from -$9K to -$2K.
What is the long-term trend for Opko Health's equity in earnings (losses) of equity method investees?
Over 4 years (2021 to 2025), Opko Health's equity in earnings (losses) of equity method investees has grown at a -53.7% compound annual growth rate (CAGR), from -$629K to -$29K.